Antipsychotics for people with dementia
- 9 July 2008
- Vol. 337 (7661), a602
- https://doi.org/10.1136/bmj.a602
Abstract
NotesCite this as: BMJ 2008;337:a602This publication has 11 references indexed in Scilit:
- A Randomised, Blinded, Placebo-Controlled Trial in Dementia Patients Continuing or Stopping Neuroleptics (The DART-AD Trial)PLoS Medicine, 2008
- Donepezil for the Treatment of Agitation in Alzheimer's DiseaseNew England Journal of Medicine, 2007
- Antipsychotic Drug Use and Mortality in Older Adults with DementiaAnnals of Internal Medicine, 2007
- The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta‐analysis of 4 placebo‐controlled clinical trialsInternational Journal of Geriatric Psychiatry, 2007
- Effectiveness of Nonpharmacological Interventions for the Management of Neuropsychiatric Symptoms in Patients With DementiaArchives of Internal Medicine, 2006
- Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-analysis of Randomized, Placebo-Controlled TrialsAmerican Journal of Geriatric Psychiatry, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Risk of Death With Atypical Antipsychotic Drug Treatment for DementiaJama-Journal Of The American Medical Association, 2005
- Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studiesInternational Journal of Geriatric Psychiatry, 2005
- Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort studyBMJ, 2005